Cactus Acquisition Corp. 1 Ltd (Nasdaq: CCTS) is a blank-check special purpose acquisition company sponsored by Cactus Healthcare Holdings Ltd that completed its initial public offering in 2022. The vehicle was formed to pursue a business combination target in the healthcare and life sciences sector, with a stated focus on Israeli-domiciled or Israel-connected companies. As of its 10-Q filing dated November 15, 2024, the company remained in its search phase, continuing to report as a registered public entity under SEC requirements. The quarterly filing, carrying accession number 0001437749-24-035486, reflects the company's ongoing compliance obligations while management evaluates prospective merger candidates. For complete filing history, sponsor details, and deal-status tracking on CCTS, sign up for full data access at SpacDesk.